Tarsus issues 'call to action' months before FDA decision on eye mite treatment
Tarsus Pharmaceuticals has a message for patients who think they may have Demodex blepharitis or irritated eyes caused by tiny mites: “Don’t freak out. Get checked out.”
The new unbranded campaign launched on Monday, just a few months before the FDA is expected to make a decision on Tarsus’ treatment, a version of the common veterinary drug lotilaner used to prevent tick and flea infestations in dogs. An approval would mark the first time the drug has been cleared for humans. While Tarsus’ last campaign, “Look at the Lids,” targeted eyecare professionals, this one aims to educate patients about the symptoms and diagnosis of Demodex blepharitis.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
